William Blair analyst Myles Minter initiated coverage of Neumora Therapeutics with an Outperform rating.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NMRA:
- Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
- Neumora Therapeutics initiated with an Outperform at RBC Capital
- Neumora Therapeutics initiated with a Buy at Stifel
- Opening Day: Specialty Asian grocer Maison Solutions opens for trading